Latest Proof Snapshot
The freshest reported quarter is fiscal Q3 2026, released on 30 April 2026. Q3 sales rose 11% to $5.486 bn and organic sales rose 6.5%; reported diluted EPS was $7.06, down 4% because the prior-year quarter included a $180 m / $1.37 discrete tax benefit, while adjusted diluted EPS was $8.17, up 18%. The valuation test for the nine months: net sales were $15.744 bn, common net income was $2.557 bn, operating cash flow was $2.628 bn, capex was $286 m, and derived strict post-capex cash, defined as OCF less capex, was $2.342 bn. Management raised FY2026 guidance to about 7% reported sales growth, 5.5% organic growth, 23.9% reported segment operating margin, 27.2% adjusted segment operating margin, reported EPS of about $27.10 and adjusted EPS of about $31.20.